Sign in
Taking people in United StatesNo phase

Checking lung screening participants for COPD using breath tests and scans

Looks at how common COPD is among adults getting lung cancer screening scans.

Key facts

Who runs it
Temple University
Where
Philadelphia, United StatesSee the site
Trial code
Registry title
Temple Health Chest Initiative (THCI 2.0)
Status
Recruiting
People taking part
1,000 people, planned
Started
28 Feb 2025
Planned end
30 Jun 2026
Type of study
Observational
Treatments tested
  • Determine COPD prevalence utilizing spirometry along with CT scans and symptom assessments in the THCI lung cancer screening populatio
Record updated
18 April 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 50 to 80 who are being screened for early lung cancer with a low dose CT scan. It checks how common COPD is in this group.

Age
50 to 80 years old
Sex
All sexes can join.

Main reasons for not taking part

  • Under 50 or over 80 years old
  • Not having lung cancer screening

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • 50 to 80 years old
  • Screened for early lung cancer using low dose CT imaging

Who cannot take part

  • No lung cancer screening
  • Under 50; over 80 years old

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 80 years old?

Where in United States

  • Temple University Of the Commonwealth System of Higher EducationPhiladelphia, United StatesContact: Lauren Miller, BSTaking people

About the trial

What the trial wants to find out

Chronic obstructive pulmonary disease is highly prevalent globally, with considerable morbidity and mortality associated. In the US, it is the 4th leading cause of death, as well as contributing to significant costs on healthcare utilization including hospitalization. Population-based screening for COPD has not been recommended by the US Preventative Services Task Force (USPSTF). However, LDCT screening for lung cancer in patients aged 50- 80 with ≥ 20 pack year smoking has been shown to improve survival. COPD is highly prevalent within LCS programs, with estimated rates of obstructive lung function of up to 59% and evidence of emphysema on CT scan in around 70%.

The group in the trial

  • Pulmonary function testing

    If the patient does have airflow obstruction (any severity) they will be contacted to complete additional questionnaires.

    Treatment: Determine COPD prevalence utilizing spirometry along with CT scans and symptom assessments in the THCI lung cancer screening populatio

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Temple Health Chest Initiative (THCI 2.0) - Lung Cancer Screening Project With COPD Detection
Plain-language title
Checking lung screening participants for COPD using breath tests and scansGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06933758, who can take part
Record updated
18 April 2025